Baxter International (NYSE:BAX) Shares Acquired Rep. Lisa C. McClain

Key Points

• Representative Lisa C. McClain purchased shares of Baxter International Inc. (NYSE:BAX) for an amount between $1,001 and $15,000 on July 22nd, 2025.
• Baxter's recent earnings report showed a missed EPS estimate of $0.59, compared to the expected $0.60, with revenues of $2.81 billion for the quarter.
• The company has announced a quarterly dividend of $0.17 per share, which will be paid on October 1st, resulting in a yield of 2.8%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Baxter International Inc. NYSE: BAX. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Baxter International stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Baxter International Price Performance

BAX traded down $0.24 on Friday, hitting $24.21. 1,266,979 shares of the company were exchanged, compared to its average volume of 5,244,159. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.49 and a current ratio of 2.30. The business's fifty day moving average is $28.29 and its 200 day moving average is $30.51. Baxter International Inc. has a fifty-two week low of $21.33 and a fifty-two week high of $40.49. The firm has a market capitalization of $12.44 billion, a P/E ratio of -80.92, a price-to-earnings-growth ratio of 0.78 and a beta of 0.59.

Baxter International (NYSE:BAX - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.01). Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%. The company had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.82 billion. During the same quarter in the previous year, the company posted $0.68 earnings per share. The company's quarterly revenue was up 4.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 2.8%. The ex-dividend date is Friday, August 29th. Baxter International's dividend payout ratio is presently -226.67%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Stifel Nicolaus restated a "hold" rating and set a $25.00 target price (down from $36.00) on shares of Baxter International in a research report on Monday, August 4th. Evercore ISI reduced their price target on shares of Baxter International from $44.00 to $42.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Morgan Stanley reduced their price target on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. Wall Street Zen downgraded shares of Baxter International from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Finally, Barclays reduced their price target on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Baxter International currently has an average rating of "Hold" and an average target price of $30.11.

Hedge Funds Weigh In On Baxter International

Several institutional investors and hedge funds have recently modified their holdings of the company. Zions Bancorporation National Association UT purchased a new position in Baxter International during the first quarter worth approximately $27,000. Rossby Financial LCC acquired a new position in shares of Baxter International during the 1st quarter valued at $29,000. CoreFirst Bank & Trust acquired a new position in shares of Baxter International during the 2nd quarter valued at $27,000. Creative Financial Designs Inc. ADV lifted its holdings in shares of Baxter International by 169.6% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier's stock valued at $30,000 after acquiring an additional 619 shares in the last quarter. Finally, MTM Investment Management LLC acquired a new position in shares of Baxter International during the 2nd quarter valued at $30,000. Hedge funds and other institutional investors own 90.19% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.